| Treatment group (N = 28) | Comparator (N = 30) | p-value |
---|---|---|---|
Karyotype | N (%) | Â | |
Simple X monosomy (45, X) | 3 (10.71) | 1 (3.33) | 0.345 b |
Structural abnormalities of the X chromosome (e.g. 46, X, i [Xq], 46, X, Xq or Xp [short or long arm deletions]) | 6 (21.43) | 5 (16.67) | 0.644 a |
Mosaic Karyotypes | 19 (67.86) | 24 (80.00) | 0.291 a |
a. 45, X/46, XX | 3 (10.71) | 7 (23.33) | 0.301 b |
b. 45, X/46, XY or 46, XY Yvar/Ydel | 2 (7.14) | 2 (6.67) | 1.000 b |
c. 45, X/46, X, i (Xq) or other structural chromosome abnormality | 14 (50.00) | 15 (50.00) | 1.000 a |
Baseline characteristic | Mean ± SD |  | |
Chronological age (year) | 6.84 ± 2.62 | 7.06 ± 2.96 | 0.883 d |
Bone Age (year) | 6.03 ± 2.93 | 5.96 ± 2.63 | 0.919 d |
Height (cm) | 106.72 ± 13.49 | 106.93 ± 14.91 | 0.955 c |
Height SDS | −2.36 ± 0.64 | −2.44 ± 0.58 | 0.450 d |
Body Weight (kg) | 20.64 ± 8.56 | 20.88 ± 7.31 | 0.686 d |
BMI (kg/m2) | 17.35 ± 3.16 | 17.64 ± 2.46 | 0.339 d |
TSH (uIU/ml) | 3.20 ± 1.64 | 3.01 ± 1.52 | 0.619 d |
fT4 (ng/dl) | 1.40 ± 0.26 | 1.37 ± 0.20 | 0.889 d |
IGF-1 (ng/ml) | 146.57 ± 52.20 | 143.15 ± 62.96 | 0.981 d |
IGFBP-3 (ug/ml) | 3.95 ± 0.98 | 3.56 ± 0.68 | 0.083 c |